DCI PARTNERS
DCI Partners is a venture capital firm specializing in the fields of drug discovery and regenerative medicine.
DCI PARTNERS
Industry:
Finance Financial Services
Founded:
2014-05-20
Status:
Active
Contact:
03-5555-6336
Email Addresses:
[email protected]
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-06-06 | LUCA Science | DCI Partners investment in Series B - LUCA Science | 3.86 B JPY |
| 2021-08-23 | Elixiron Immunotherapeutics | DCI Partners investment in Series A - Elixiron Immunotherapeutics | N/A |
| 2019-03-11 | Renascience | DCI Partners investment in Series B - Renascience | 50 M JPY |
| 2018-12-17 | Junten Bio | DCI Partners investment in Venture Round - Junten Bio | 1.45 B JPY |
| 2018-12-07 | StemRIM | DCI Partners investment in Venture Round - StemRIM | 699.93 M JPY |
| 2018-05-31 | Noile-Immune Biotech | DCI Partners investment in Venture Round - Noile-Immune Biotech | 60.01 M JPY |
| 2018-02-28 | Renascience | DCI Partners investment in Series A - Renascience | 740 M JPY |
| 2018-01-16 | APRINOIA Therapeutics | DCI Partners investment in Series B - APRINOIA Therapeutics | 11.1 M USD |
| 2017-03-15 | Momotaro-Gene | DCI Partners investment in Venture Round - Momotaro-Gene | 1.12 B JPY |
| 2016-02-02 | BONAC | DCI Partners investment in Venture Round - BONAC | 2.5 B JPY |